THYMINE KINASE 2 DEFICIENCY

Clinical trials for THYMINE KINASE 2 DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new THYMINE KINASE 2 DEFICIENCY trials appear

Sign up with your email to follow new studies for THYMINE KINASE 2 DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Lifeline offered for rare genetic disorder as experimental drugs become available outside clinical trials

Disease control AVAILABLE

This program provides early access to the investigational drugs doxecitine and doxribtimine for patients with Thymine Kinase 2 Deficiency (TK2d), a rare genetic disorder that causes muscle weakness and can be life-threatening. It's designed for patients who cannot participate in …

Matched conditions: THYMINE KINASE 2 DEFICIENCY

Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

THYMINE KINASE 2 DEFICIENCY

Get alerted when new THYMINE KINASE 2 DEFICIENCY trials appear

Lifeline offered for rare genetic disorder as experimental drugs become available outside clinical trials